Co-Chairs

Gordon L. Amidon, Ph.D. (University of Michigan, USA)
Mitsuru Hashida, Ph.D. (Kyoto University, Japan)
Masatoshi Narita (Ministry of Health, Labour and Welfare, Japan)
Vinod P. Shah, Ph.D. (International Pharmaceutical Federation, USA)
Shinji Yamashita, Ph.D. (Setsunan University, Japan)
Chikako Yomota, Ph.D. (National Institute of Health Sciences, Japan)

International Advisory Board

Dirk Barends, Ph.D. (National Institute of Public Health and the Environment, Netherlands)
Leslie Z. Benet, Ph.D. (University of California, San Francisco, USA)
Soo Youn Chung, Ph.D. (Korea Food and Drug Administration, Korea)
Jennifer Dressman, Ph.D. (Goethe University, Germany)
Peter Langguth, Ph.D. (University of Mainz, Germany)
Vincent H.L. Lee, Ph.D. (Chinese University of Hong Kong, Hong Kong)
Hans Lennernas, Ph.D. (Uppsala University, Sweden)
Tsuneji Nagai, Ph.D. (The Nagai Foundation Tokyo, Japan)
James Polli, Ph.D. (University of Maryland, USA)
Yuichi Sugiyama , Ph.D. (University of Tokyo, Japan)
Ikumi Tamai, Ph.D. (Kanazawa University, Japan)
Jan Welink, Ph.D. (European Medicines Evaluation Board, Netherlands)
Lawrence Yu, Ph.D. (Food and Drug Administration, USA)

Programming Committee

Bertil Abrahamsson, Ph.D. (AstraZeneca, Sweden)
Marival Bermejo, Ph.D. (Universidad de Valencia, Spain)
Michael B. Bolger, Ph.D. (University of Southern California, USA)
Jack A. Cook, Ph.D. (Pfizer, USA)
Takuya Fujita, Ph.D. (Ritsumeikan University, Japan)
Ping Gao, Ph.D. (Abbott Laboratories, Inc, USA)
Kazutaka Higaki, Ph.D. (Okayama University, Japan)
Beom-Jin Lee, Ph.D. (Kangwon National University, Korea)
Kyung-Dall Lee, Ph.D. (University of Michigan, USA)
Mariko Morishita, Ph.D. (Hoshi University, Japan)
Noriyuki Muranushi, Ph.D. (Shionogi & Co. Ltd, Japan)
Shinji Sakuma, Ph.D. (Setsunan University, Japan)
Ryusuke Takano, Ph.D. (Chugai Pharmaceutical Co., Japan)
Fumiyoshi Yamashita, Ph.D. (Kyoto University, Japan)